Dopamine D2 receptor antagonists prevent Δ9-tetrahydrocannabinol-induced antinociception in rats
- 19 November 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 384 (2-3) , 153-156
- https://doi.org/10.1016/s0014-2999(99)00696-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effects of dopaminergic agents on antinociception in formalin testGeneral Pharmacology: The Vascular System, 1999
- Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists Δ9-THC, WIN 55,212-2 and anandamide in miceNeuroscience Letters, 1999
- Increase in meso‐prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoidsEuropean Journal of Neuroscience, 1998
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptorsEuropean Journal of Pharmacology, 1998
- Δ9-Tetrahydroeannabinol enhances presynaptic dopamine efflux In medial prefrontal cortexEuropean Journal of Pharmacology, 1990
- Involvement of dopamine in the antinociceptive response to footshockPsychopharmacology, 1984